Two Indian pharmaceutical companies - Cipla and Hetero - have received the permission to manufacture the Covid 19 drug Remdesivir in India. It is said that Remdesivir can be used as a treatment of Covid 19.
 |
| Currently, two Indian companies have been allowed to manufacture Remdesivir drugs |
The pharmaceutical company Gilead Sciences has developed the drug Remdesivir. It is said that Remdesivir can be used as a treatment of Covid 19. This drug is even being tested as a specific treatment for Covid 19. In the meantime, the United States, India, and Japan have approved the use of the drug in severe cases of the corona virus. It is said that the drug Remdesivir can cure Covid 19 infected patients quickly.
Gilead Sciences is Amarecan biopharmaceutical company that researches, develops and commercializes drugs. The Company is headquartered in Foster City, California.
Coronavirus infection is on the rise and the demand for these drugs in the country. In this situation, The Drug Controller General of India(DCGI)also allowed Gilead to sell the drug in India.
 |
| The drug can only be used on an emergency basis in critical corona patients |
Currently, two Indian companies have been allowed to manufacture Remdesivir drugs.
It is reported that five local companies had applied to manufacturer the Remdesivir. Among them, Cipla and Hetero, these two companies have received permission to manufacture the drug in India. According to the Drug Controller General of India(DCGI), the drug can only be used on an emergency basis in critical corona patients. Corona virus (Covid 19) drugs are expected to hit the market by the end of June.
Side effects
low blood pressure, nausea, vomiting, sweating, and shivering. Increases in levels of liver enzymes, seen in abnormal liver blood tests. Increases in levels of liver enzymes have been seen in people who have received remdesivir, which may be a sign of inflammation or damage to cells in the liver.